Preparation of Burkholderia pseudomallei Polysaccharide-CRM197 Conjugate, a Potential Vaccine Candidate for Glanders and Melioidosis
Abstract
CURRENT STATUS TREATMENT OF MELIOIDOSIS AND GLANDERS: (1) Burkholderia mallei and B. pseudomallei are the causative agents for glanders and melioidosis, respectively; (2) Both of these organisms have been considered as potential agents for biological warfare and biological terrorism; (3) Currently, these infections are treated with antibiotics; (4) Currently, no vaccines are available for protection against glanders and melioidosis.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2005
- Accession Number
- ADA449777
Entities
People
- David Deshazer
- David Waag
- Marilyn England
- Narayanan Parthasarathy
- Rodjimil Barrais
Organizations
- United States Army Medical Research Institute of Infectious Diseases